Literature DB >> 3708212

A protective effect of sulphinpyrazone against coronary occlusion-induced shortening of myocardial refractory periods in the rat.

B J Northover.   

Abstract

The hearts of anaesthetized, artificially ventilated rats were exposed, and the left coronary artery occluded. The diastolic threshold voltage for stimulation (DTV), the duration of the bipolar electrogram (DBE) and the functional refractory period (FRP) of the ischaemic area were measured at minute intervals for an hour after occlusion. Coronary occlusion caused a rise in DTV, a prolongation of the DBE and a biphasic change in the FRP, with an initial prolongation phase (1-4 min) followed by a decline to below pre-occlusion values (5-15 min). Episodes of ventricular tachyarrhythmia (VT) were most frequent during the period 5-15 min after the onset of occlusion of the coronary artery. This coincided with the period when FRP was minimal and the difference between DBE and FRP was maximal. Pretreatment of rats with sulphinpyrazone (2.5-40 mg kg-1) or indomethacin (5-20 mg kg-1) protected against the episodes of coronary occlusion-induced VT and against the associated decline in FRP of the ischaemic muscle. Sulphinpyrazone was more effective than indomethacin in this respect and a combination of the two drugs was approximately as effective as sulphinpyrazone alone. It was concluded that sulphinpyrazone protects rats against coronary occlusion-induced episodes of VT by reducing the risk of ventricular action potential re-entry. This effect is probably due to protection against the ischaemia-induced shortening of the myocardial FRP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708212      PMCID: PMC1917107          DOI: 10.1111/j.1476-5381.1986.tb09480.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Electrophysiological and mechanical effects of sulphinpyrazone on isolated rat atria.

Authors:  O Kristiansen; H Refsum; R Hotvedt
Journal:  Clin Physiol       Date:  1982-08

2.  Changes in myocardial refractory periods following ischemia in the porcine heart.

Authors:  J K Bissett; J W Watson; J A Scovil; N Schmidt; J R McConnell; J Kane
Journal:  J Electrocardiol       Date:  1979-01       Impact factor: 1.438

3.  Influence of sulfinpyrazone and naproxen on infarct size in the dog.

Authors:  R Bolli; R E Goldstein; N Davenport; S E Epstein
Journal:  Am J Cardiol       Date:  1981-04       Impact factor: 2.778

4.  Electrophysiological effects of sulfinpyrazone on canine cardiac Purkinje fibers.

Authors:  D G Benditt; A O Grant; A B Hutchison; H C Strauss
Journal:  Can J Physiol Pharmacol       Date:  1980-06       Impact factor: 2.273

5.  Transmembrane potential changes and ventricular fibrillation during repetitive myocardial ischaemia in the dog.

Authors:  D C Russell; J H Smith; M F Oliver
Journal:  Br Heart J       Date:  1979-07

6.  Alterations in canine myocardial excitability during ischemia.

Authors:  V Elharrar; P R Foster; T L Jirak; W E Gaum; D P Zipes
Journal:  Circ Res       Date:  1977-01       Impact factor: 17.367

7.  Long-term preservation of ischemic myocardium after experimental coronary artery occlusion.

Authors:  D Maclean; M C Fishbein; E Braunwald; P R Maroko
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Sulfinpyrazone in the prevention of sudden death after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

9.  Dose-related cardiac electrophysiologic effects of sulfinpyrazone.

Authors:  D G Wyse
Journal:  Clin Pharmacol Ther       Date:  1985-02       Impact factor: 6.875

10.  Influence of sulfinpyrazone on infarct size, hemodynamics, and arrhythmia following coronary occlusion in the pig.

Authors:  R C Stäubli; H R Baur; U Althaus; H P Pop; H P Wehrli; H P Gurtner
Journal:  J Cardiovasc Pharmacol       Date:  1984 Sep-Oct       Impact factor: 3.105

View more
  2 in total

1.  Electrical changes produced by injury to the rat myocardium in vitro and the protective effects of certain antiarrhythmic drugs.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

2.  Protection of rat atrial myocardium against electrical, mechanical and structural aspects of injury caused by exposure in vitro to conditions of simulated ischaemia.

Authors:  A M Northover; B J Northover
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.